[Impact of the Overlap Region Between Acoustic and Electric Stimulation].
Patients with residual hearing in the low frequencies and ski-slope hearing loss with partial deafness at medium and high frequencies receive a cochlear implant treatment with electric-acoustic stimulation (EAS, "hybrid" stimulation). In the border region between electric and acoustic stimulation a superposition of the 2 types of stimulation is expected. The area of overlap is determined by the insertion depth of the stimulating electrode and the lower starting point of signal transmission provided by the CI speech processor. The study examined the influence of the variation of the electric-acoustic overlap area on speech perception in noise, whereby the width of the "transmission gap" between the 2 different stimulus modalities was varied by 2 different methods. The results derived from 9 experienced users of the MED-EL Duet 2 speech processor show that the electric-acoustic overlapping area and with it the crossover frequency between the acoustic part and the CI should be adjusted individually. Overall, speech reception thresholds (SRT) showed a wide variation of results in between subjects. Further studies shall investigate whether generalized procedures about the setting of the overlap between electric and acoustic stimulation are reasonable, whereby an increased number of subjects and a longer period of acclimatization prior to the conduction of hearing tests deemed necessary.
Audiologische Akustik, Klinik für Hals- Nasen- Ohrenheilkunde, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt, Frankfurt am Main.
Uwe
U
Baumann
Dr. Horst Schmidt Klinik, HNO Abteilung, Wiesbaden.
Moritz
M
Mocka
D000161:Acoustic Stimulation; D001300:Audiometry, Evoked Response / Q000379:methods / Q000706:statistics & numerical data; D003430:Cross-Sectional Studies; D005858:Germany; D005865:Gestational Age; D019983:Guideline Adherence; D006319:Hearing Loss, Sensorineural / Q000151:congenital / Q000453:epidemiology / Q000628:therapy*; D006320:Hearing Tests / Q000379:methods* / Q000706:statistics & numerical data; D006785:Hospitals, University / Q000706:statistics & numerical data; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000453:epidemiology / Q000628:therapy*; D015997:Neonatal Screening / Q000706:statistics & numerical data; D012189:Retrospective Studies; D012307:Risk Factors; D014600:Utilization Review / Q000706:statistics & numerical data